• Accueil >
  • Publications >
  • Feasibility of Busulfan Melphalan and Stem Cell Rescue After 131I-MIBG and Topotecan Therapy for Refractory or Relapsed Metastatic Neuroblastoma: The French Experience

Feasibility of Busulfan Melphalan and Stem Cell Rescue After 131I-MIBG and Topotecan Therapy for Refractory or Relapsed Metastatic Neuroblastoma: The French Experience

1 août 2018Journal of Pediatric Hematology/Oncology

DOI : 10.1097/mph.0000000000001137

Auteurs

Isabelle Ferry, Hélène Kolesnikov-Gauthier, Aurore Oudoux, Olivier Cougnenc, Gudrun Schleiermacher, Jean Michon, Emilie Bogart, Pascal Chastagner, Stéphanie Proust, Dominique Valteau-Couanet, Anne-Sophie Defachelles